|
CpG Islands
|
G05.360.080.380.160 |
|
|
GC Rich Sequence
|
G05.360.080.380 |
|
|
Hydroxyindoleacetic Acid
|
D006897 |
|
|
Hydroxylamines
|
D006898 |
[Organic compounds that contain the (-NH2OH) radical.
] |
|
Mixed Function Oxygenases
|
D006899 |
[Widely distributed enzymes that carry out oxidation-reduction reactions in which one atom of the oxygen molecule is incorporated into the organic substrate; the other oxygen atom is reduced and combined with hydrogen ions to form water. They are also known as monooxygenases or hydroxylases. These reactions require two substrates as reductants for each of the two oxygen atoms. There are different classes of monooxygenases depending on the type of hydrogen-providing cosubstrate (COENZYMES) required in the mixed-function oxidation.
] |
|
Hydroxyeicosatetraenoic Acids
|
D006893 |
[Eicosatetraenoic acids substituted in any position by one or more hydroxy groups. They are important intermediates in a series of biosynthetic processes leading from arachidonic acid to a number of biologically active compounds such as prostaglandins, thromboxanes, and leukotrienes.
] |
|
Oocyte Donation
|
E02.875.800.968 |
|
|
Hydroxyestrones
|
D006894 |
[Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
] |
|
TNF Receptor-Associated Factor 4
|
D12.776.476.024.500.906 |
|
|
Hydroxyethyl Starch Derivatives
|
D006895 |
[Starches that have been chemically modified so that a percentage of OH groups are substituted with 2-hydroxyethyl ether groups.
, Hydroxyethyl starch derivative with five hydroxyethyl groups.
] |
|
Hydroxyethylrutoside
|
D006896 |
[Monohydroxyethyl derivative of rutin. Peripheral circulation stimulant used in treatment of venous disorders.
] |
|
Animal Technicians
|
M01.526.485.067.040 |
|
|
Immunotherapy, Adoptive
|
D016219 |
[Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
] |
|
Receptors, sigma
|
D12.776.543.750.720.600.610.775 |
|
|
Rhodocyclaceae
|
B03.660.075.655 |
|
|
Betaproteobacteria
|
B03.660.075 |
|
|
Transforming Growth Factor beta
|
D016212 |
[A factor synthesized in a wide variety of tissues. It acts synergistically with TGF-alpha in inducing phenotypic transformation and can also act as a negative autocrine growth factor. TGF-beta has a potential role in embryonal development, cellular differentiation, hormone secretion, and immune function. TGF-beta is found mostly as homodimer forms of separate gene products TGF-beta1, TGF-beta2 or TGF-beta3. Heterodimers composed of TGF-beta1 and 2 (TGF-beta1.2) or of TGF-beta2 and 3 (TGF-beta2.3) have been isolated. The TGF-beta proteins are synthesized as precursor proteins.
] |
|
Cyclins
|
D016213 |
[A large family of regulatory proteins that function as accessory subunits to a variety of CYCLIN-DEPENDENT KINASES. They generally function as ENZYME ACTIVATORS that drive the CELL CYCLE through transitions between phases. A subset of cyclins may also function as transcriptional regulators.
] |
|
Methacholine Chloride
|
D016210 |
[A quaternary ammonium parasympathomimetic agent with the muscarinic actions of ACETYLCHOLINE. It is hydrolyzed by ACETYLCHOLINESTERASE at a considerably slower rate than ACETYLCHOLINE and is more resistant to hydrolysis by nonspecific CHOLINESTERASES so that its actions are more prolonged. It is used as a parasympathomimetic bronchoconstrictor agent and as a diagnostic aid for bronchial asthma. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1116)
] |
|
Transforming Growth Factor alpha
|
D016211 |
[An EPIDERMAL GROWTH FACTOR related protein that is found in a variety of tissues including EPITHELIUM, and maternal DECIDUA. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form which binds to the EGF RECEPTOR.
] |
